Dr. Filicko-O’Hara specializes in the management of hematologic cancers and the use of stem cell transplantation for both malignant and non-malignant conditions, including sickle cell anemia. Her clinical expertise is complemented by active contributions to research on immune reconstitution following stem cell transplantation and the evaluation of treatment regimens for hematologic malignancies.
She has co-authored publications on a range of topics, including the use of bendamustine in combination therapies for relapsed or refractory aggressive B-cell non-Hodgkin lymphoma, as well as the treatment of adenovirus disease in stem cell transplant recipients.